go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Pfizer Healthcare Ireland
9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24,
Telephone: +353 1 467 6500
Fax: +353 1 467 6501
Medical Information Direct Line: 1 800 633 363
Patient Information Leaflet last updated on medicines.ie: 13/01/2012
PIL Enbrel 25mg solution for injection in pre-filled syringe

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 13/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to packaging
Updated on 21/10/2011 and displayed until 13/01/2012
Reasons for adding or updating:
  • Change to storage instructions
Updated on 23/09/2011 and displayed until 21/10/2011
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 23/08/2011 and displayed until 23/09/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to marketing authorisation holder
Updated on 22/07/2011 and displayed until 23/08/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 10/06/2011 and displayed until 22/07/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 31/05/2011 and displayed until 10/06/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 08/03/2011 and displayed until 31/05/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 04/02/2011 and displayed until 08/03/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to dosage and administration
Updated on 16/12/2010 and displayed until 04/02/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 30/07/2010 and displayed until 16/12/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 05/07/2010 and displayed until 30/07/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to MA holder contact details
Updated on 18/01/2010 and displayed until 05/07/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to MA holder contact details
Updated on 26/08/2009 and displayed until 18/01/2010
Reasons for adding or updating:
  • Change to storage instructions
  • Change to improve clarity and readability
Updated on 17/07/2009 and displayed until 26/08/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 18/05/2009 and displayed until 17/07/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 03/10/2008 and displayed until 18/05/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Addition of marketing authorisation holder
Updated on 01/08/2008 and displayed until 03/10/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to dosage and administration
Updated on 18/12/2007 and displayed until 01/08/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 15/10/2007 and displayed until 18/12/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to further information section
  • Change to dosage and administration
Updated on 16/05/2007 and displayed until 15/10/2007
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to further information section
Updated on 07/02/2007 and displayed until 16/05/2007
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 14/12/2006 and displayed until 07/02/2007
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 10/11/2006 and displayed until 14/12/2006
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Etanercept